Delivery Order SPE2DB20D3101-SPE2DB23FRAT1

Award Date 1/23/23
Potential Completion Date 1/24/23
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,339.47 firm fixed-price delivery order is for the supply of RENFLEXIS 100 MG VIALS medical products. The contract has an ultimate completion date of November 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,649.63 firm fixed-price delivery order is for the supply of RENFLEXIS 100 MG VIALS, a specialty pharmaceutical product. The contract has an ultimate completion date of February 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,941.94 firm fixed-price delivery order is for the supply of RENFLEXIS 100 MG VIALS, a pharmaceutical product. The award has an ultimate completion date of November 8, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,945.14 firm fixed-price delivery order contract is for the supply of RENFLEXIS 100 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of June 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is a delivery order valued at $6,187.34 placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RENFLEXIS 100 MG VIALS, a pharmaceutical product, to support military healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $32,049.10, is a delivery order for the supply of 4567364345 RENFLEXIS 100 MG VIALS. The contract has a firm fixed-price pricing type and an ultimate completion date of February 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,466.82 delivery order is for the supply of RENFLEXIS 100 MG VIALS and has a firm fixed price. The contract has an ultimate completion date of August 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $6,529.60 Firm Fixed Price Delivery Order is for the supply of RENFLEXIS 100 MG VIALS, which are pharmaceutical products. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,502.80 fixed-price delivery order is for the supply of RENFLEXIS 100 MG VIALS, with an ultimate completion date of October 2, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,077.44, is for the delivery of RENFLEXIS 100 MG VIALS, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 23, 2024. The award was not designated as a set-aside contract. AmerisourceBergen holds a...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRAT1
    Delivery Order

This federal contract award is a delivery order with the Defense Logistics Agency (DLA) valued at $4,716.99 for the supply of RENFLEXIS 100 MG VIALS by AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price and is set to be completed by January 24, 2023. AmerisourceBergen maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated with a set-aside requirement, indicating open competition.

Generated 2/27/25, 12:44 PM